Age and tumor size predicts lymph node involvement in Hürthle cell carcinoma

Journal of Cancer

Volumn 1, Issue 1, 2010, Pages 23-26

  Guerrero, Marlon A ^a   Suh, Insoo ^b   Vriens, Menno R ^b   Shen, Wen T ^b   Gosnell, Jessica ^b   Kebebew, Electron ^c   Duh, Quan Yang ^b   Clark, Orlo H ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Age; Hurthle cell carcinoma; Lymph node metastasis; Prediction; Tumor size

Indexed keywords

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER INVASION; CANCER PATIENT; CANCER RISK; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; FEMALE; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; HURTHLE CELL CARCINOMA; INTRAOPERATIVE PERIOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; ONCOCYTOMA; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; RETROSPECTIVE STUDY; RISK FACTOR; STUDENT T TEST; SUBTOTAL THYROIDECTOMY; THYROID CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 84860456721     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.1.23     Document Type: Article

References (11)

1. Chen H, Nicol TL, Zeiger MA, et al. Hürthle cell neoplasms of the thyroid: are there factors predictive of malignancy? Ann Surg. 1998; 227: 542-6.
2. McHenry CR, Thomas SR, Slusarczyk SJ, Khiyami A. Follicular or Hürthle cell neoplasm of the thyroid: can clinical factors be used to predict carcinoma and determine extent of thyroidectomy? Surgery. 1999; 126: 798-802.
3. Kushchayeva Y, Duh QY, Kebebew E, Clark OH. Prognostic indications for Hürthle cell cancer. World J Surg. 2004; 28: 1266-70.
4. Giorgadze T, Rossi ED, Fadda G, et al. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy? Diagn Cytopathol. 2004; 31: 307-12.
5. Sippel RS, Elaraj DM, Khanafshar E, et al. Tumor size predicts malignant potential in Hürthle cell neoplasms of the thyroid. World J Surg. 2008; 32: 702-7.
6. Pisanu A, Sias L, Uccheddu A. Factors predicting malignancy of Hürthle cell tumors of the thyroid: influence on surgical treatment. World J Surg. 2004; 28: 761-5.
7. Lopez-Penabad L, Chiu AC, Hoff AO, et al. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid. Cancer. 2003; 97: 1186-94.
8. Zhang YW, Greenblatt DY, Repplinger D, et al. Older age and larger tumor size predict malignancy in hürthle cell neoplasms of the thyroid. Ann Surg Oncol. 2008; 15: 2842-6.
9. Stojadinovic A, Hoos A, Ghossein RA, et al. Hürthle cell carcinoma: a 60-year experience. Ann Surg Oncol. 2002; 9: 197-203.
10. Mills SC, Haq M, Smellie WJ, Harmer C. Hürthle cell carcinoma of the thyroid: Retrospective review of 62 patients treated at the Royal Marsden Hospital between 1946 and 2003. Eur J Surg Oncol. 2009; 35:230-4.
11. Soh EY, Clark OH. Surgical considerations and approach to thyroid cancer. Endocrinol Metab Clin North Am. 1996; 25: 115-39.